Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO13363-T1

Drug Field of development:

Genito Urinary System Therapy Area:

Target Type of patent:

Ppar-gamma agonist as target for the treatment of rapidly progressive

This study demonstrates the pivotal role of the local PPAR-gamma agonist system in maintaining podocyte quiescence and orchestrating the global […]

BIO19208-T1

Drug Field of development:

Genito Urinary System Therapy Area:

Target Type of patent:

Use of cd9 as a biomarker and as a biotarget in glomerulonephritis

The mechanisms driving the development of extracapillary lesions in focal segmental glomerulosclerosis (FSGS) and crescentic glomerulonephritis (CGN) […]

BIO10870-T1

Drug Field of development:

Genito Urinary System Therapy Area:

Target Type of patent:

Ngal as a novel target for the treatment of chronic kidney disease

The severity of renal lesions after nephron reduction varied substantially among mouse strains and required activation of EGFR. Lipocalin 2 (Lcn2, […]

BIO20556-D1

Biomarker Field of development:

Polycystic kidney disease Therapy Area:

Biomarker Type of patent:

Methods and compositions for detecting the activation of mtor pathway

The present invention relates to a method for measuring the activation of mTOR pathway in a subject suffering from a kidney disease associated with a […]

BIO12003-T1

Drug Field of development:

Genito Urinary System Therapy Area:

Target Type of patent:

Periostin inhibitor in the prevention or treatment of chronic kidney

The present invention relates to an agent which binds to periostin selected from the group consisting of antibodies, aptamers, small organic molecules […]

BIO10870-D1

Biomarker Field of development:

Genito Urinary System Therapy Area:

Biomarker Type of patent:

Ngal as a biomarker for predicting the evolution and treatment of

The severity of renal lesions after nephron reduction varied substantially among mouse strains and required activation of EGFR. Lipocalin 2 (Lcn2, […]

BIO19208-D1

Biomarker Field of development:

Genito Urinary System Therapy Area:

Biomarker Type of patent:

Cd9 as a new biomarker for diagnosing or predicting risk of

The mechanisms driving the development of extracapillary lesions in focal segmental glomerulosclerosis (FSGS) and crescentic glomerulonephritis (CGN) […]

147

56

310

46

Our Technology Offers

Ppar-gamma agonist as target for the treatment of rapidly progressive

Use of cd9 as a biomarker and as a biotarget in glomerulonephritis

Ngal as a novel target for the treatment of chronic kidney disease

Methods and compositions for detecting the activation of mtor pathway

Periostin inhibitor in the prevention or treatment of chronic kidney

Ngal as a biomarker for predicting the evolution and treatment of

Cd9 as a new biomarker for diagnosing or predicting risk of

You might also be interested in

Methods and compositions for detecting the

Ngal as a novel target for the treatment of

Cd9 as a new biomarker for diagnosing or

Use of cd9 as a biomarker and as a biotarget in

Ppar-gamma agonist as target for the treatment of

Periostin inhibitor in the prevention or treatment

Ngal as a biomarker for predicting the evolution